• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON & CO. (SPARKS) BD COR¿ MX; THERMAL CYCLER NUCLEIC ACID AMPLIFICATION ANALYSER IVD, LABORATORY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON & CO. (SPARKS) BD COR¿ MX; THERMAL CYCLER NUCLEIC ACID AMPLIFICATION ANALYSER IVD, LABORATORY Back to Search Results
Catalog Number 443989
Medical Device Problem Code False Positive Result (1227)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 05/21/2025
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
D2b.Mkz, ouy, qep.D.4.Medical device expiration date: unknown.A device evaluation and/or device history review is anticipated but is not complete.Upon completion, a supplemental report will be filed.
 
Event or Problem Description
It was reported during use of bd cor mx instrument there was a false positive result for all mm2 targets on the cor vaginal panel assay.Confirmatory testing was performed on bd max instrument and indicated that only one target was positive.No adverse impact was reported regarding the patient or user.
 
Additional Manufacturer Narrative
This complaint was the result of a request for information from the customer.The customer wanted to confirm the result on the mx using the vaginal panel assay.A bd field service engineer was dispatched to review run files and perform health check.The sample was repeated and the results were confirmed using the customer's bd max instrument.This complaint is an unconfirmed failure of the bd cor mx.No samples were expected to be received as part of this complaint, and therefore no samples were returned, and no returned material investigation could occur.Dhr review was conducted and there were no abnormalities related to this failure mode during manufacturing acceptance testing.Service history review revealed there was one previous complaint for this issue.Bd quality will continue to monitor for trends associated with the failure mode described in this complaint.Review of risk management files confirms there are no new or modified risks associated with this failure mode.
 
Event or Problem Description
It was reported during use of bd cor mx instrument there was a false positive result for all mm2 targets on the cor vaginal panel assay.Confirmatory testing was performed on bd max instrument and indicated that only one target was positive.No adverse impact was reported regarding the patient or user.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD COR¿ MX
Common Device Name
THERMAL CYCLER NUCLEIC ACID AMPLIFICATION ANALYSER IVD, LABORATORY
Manufacturer (Section D)
BECTON DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer (Section G)
BECTON, DICKINSON & CO. (SPARKS)
7 loveton circle
sparks MD 21152
Manufacturer Contact
matt j. connor
7 loveton circle
sparks, MD 21152
4103164000
MDR Report Key22181467
Report Number1119779-2025-00563
Device Sequence Number15607664
Product Code LSL
UDI-Device Identifier00382904439897
UDI-Public(01)00382904439897(11)221019
Combination Product (Y/N)N
Initial Reporter StateFL
Initial Reporter CountryUS
PMA/510(K) Number
K210585
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Company Representative
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 06/24/2025
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue Number443989
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/21/2025
Supplement Date Received by Manufacturer06/24/2025
Initial Report FDA Received Date06/10/2025
Supplement Report FDA Received Date07/01/2025
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured10/19/2022
Is the Device Labeled for Single Use? (Y/N) No
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-